Company Filing History:
1 out of 523 
1 out of 200 
1 out of 4,455 
Years Active: 2005-2008
Title: Mark Kontny: Innovator in Pharmaceutical Chemistry
Introduction
Mark Kontny is a notable inventor based in Libertyville, IL (US), recognized for his contributions to pharmaceutical chemistry. He holds a total of 3 patents, showcasing his innovative approach to developing new compounds and therapeutic compositions.
Latest Patents
Among his latest patents is a phenol derivative, specifically the compound 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol. This compound can be utilized to prepare another compound, (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide, through a reaction with methyl bromide. Additionally, he has developed cyclooxygenase-2 inhibitor compositions that have a rapid onset of therapeutic effect. These pharmaceutical compositions consist of one or more orally deliverable dose units, each containing a selective cyclooxygenase-2 inhibitory drug of low water solubility, which is beneficial for treating conditions mediated by cyclooxygenase-2.
Career Highlights
Mark has worked with prominent companies in the pharmaceutical industry, including Pharmacia & Upjohn Company and Pharmacia Corporation. His experience in these organizations has significantly contributed to his expertise in drug development and innovation.
Collaborations
Throughout his career, Mark has collaborated with notable colleagues such as Ivan Richards and Sue K Cammarata. These partnerships have likely enhanced his research and development efforts in the field of pharmaceuticals.
Conclusion
Mark Kontny's work in pharmaceutical chemistry exemplifies the impact of innovation in developing new therapeutic solutions. His patents and collaborations reflect a commitment to advancing medical science and improving patient care.